CUFinder

Min Hee Hong

Min Hee Hong

Yonsei University

H-index: 29

Asia-South Korea

Contact Min Hee Hong

About Min Hee Hong

Min Hee Hong, With an exceptional h-index of 29 and a recent h-index of 27 (since 2020), a distinguished researcher at Yonsei University, specializes in the field of Medical Oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

CD81 and CD82 in tumor infiltrating lymphocytes within the NSCLC tumor microenvironment play a crucial role in T cell activation and cytokine production

CJRB-101 induces immune responses through the GUT-TME axis in immune cell-driven mechanism in lung cancer models

Identification of immune suppressive features in tumor-associated endothelial cells (TECs) in EGFR-mutant non-small cell lung cancer via single-cell RNA sequencing

Exploring myeloid landscapes according to EGFR mutated NSCLC tumor microenvironment

Single-cell transcriptome analysis reveals that PLK4 signature genes are highly associated with cancer proliferation and hotspot mutations in non-small cell lung cancer (NSCLC)

CD81 and CD82 expressing tumor-infiltrating lymphocytes in the NSCLC tumor microenvironment play a crucial role in T-cell activation and cytokine production

99TiP A randomized phase II study of lazertinib alone versus lazertinib plus bevacizumab for advanced non-small cell lung cancer with epidermal growth factor receptor …

Analysis of tumor mutational burden and mutational landscape comparing whole-exome sequencing and comprehensive genomic profiling in patients with resectable early-stage non …

Min Hee Hong Information

University

Position

College of Medicine

Citations(all)

3050

Citations(since 2020)

2664

Cited By

1102

hIndex(all)

29

hIndex(since 2020)

27

i10Index(all)

58

i10Index(since 2020)

51

Email

University Profile Page

Google Scholar

Min Hee Hong Skills & Research Interests

Medical Oncology

Top articles of Min Hee Hong

CD81 and CD82 in tumor infiltrating lymphocytes within the NSCLC tumor microenvironment play a crucial role in T cell activation and cytokine production

Cancer Research

2024/3/22

Seul Lee
Seul Lee

H-Index: 6

Youngtaek Kim
Youngtaek Kim

H-Index: 1

Jae Hwan Kim
Jae Hwan Kim

H-Index: 2

Min Hee Hong
Min Hee Hong

H-Index: 16

CJRB-101 induces immune responses through the GUT-TME axis in immune cell-driven mechanism in lung cancer models

Cancer Research

2024/3/22

Jaemin Kim
Jaemin Kim

H-Index: 7

Jieun Kwon
Jieun Kwon

H-Index: 5

Jae Hwan Kim
Jae Hwan Kim

H-Index: 2

Min Hee Hong
Min Hee Hong

H-Index: 16

Identification of immune suppressive features in tumor-associated endothelial cells (TECs) in EGFR-mutant non-small cell lung cancer via single-cell RNA sequencing

Cancer Research

2024/3/22

Juhyeon Lee
Juhyeon Lee

H-Index: 2

Min Hee Hong
Min Hee Hong

H-Index: 16

Exploring myeloid landscapes according to EGFR mutated NSCLC tumor microenvironment

Cancer Research

2024/3/22

Juhyeon Lee
Juhyeon Lee

H-Index: 2

Jae Hwan Kim
Jae Hwan Kim

H-Index: 2

Min Hee Hong
Min Hee Hong

H-Index: 16

Single-cell transcriptome analysis reveals that PLK4 signature genes are highly associated with cancer proliferation and hotspot mutations in non-small cell lung cancer (NSCLC)

Cancer Research

2024/3/22

Youngtaek Kim
Youngtaek Kim

H-Index: 1

Seul Lee
Seul Lee

H-Index: 6

Min Hee Hong
Min Hee Hong

H-Index: 16

CD81 and CD82 expressing tumor-infiltrating lymphocytes in the NSCLC tumor microenvironment play a crucial role in T-cell activation and cytokine production

Frontiers in Immunology

2024/3/7

Seul Lee
Seul Lee

H-Index: 6

Youngtaek Kim
Youngtaek Kim

H-Index: 1

Jae Hwan Kim
Jae Hwan Kim

H-Index: 2

Min Hee Hong
Min Hee Hong

H-Index: 16

99TiP A randomized phase II study of lazertinib alone versus lazertinib plus bevacizumab for advanced non-small cell lung cancer with epidermal growth factor receptor …

ESMO Open

2024/3/1

Mh Hong
Mh Hong

H-Index: 55

Y Lee
Y Lee

H-Index: 3

Analysis of tumor mutational burden and mutational landscape comparing whole-exome sequencing and comprehensive genomic profiling in patients with resectable early-stage non …

Therapeutic Advances in Medical Oncology

2024/3

Jae Hwan Kim
Jae Hwan Kim

H-Index: 2

Min Hee Hong
Min Hee Hong

H-Index: 16

Personalized biomarker-based umbrella trial for patients with recurrent or metastatic head and neck squamous cell carcinoma: KCSG HN 15-16 TRIUMPH trial

Journal of Clinical Oncology

2024/2/10

Bhumsuk Keam
Bhumsuk Keam

H-Index: 42

Min Hee Hong
Min Hee Hong

H-Index: 16

Ji Eun Kim
Ji Eun Kim

H-Index: 4

Sangwoo Kim
Sangwoo Kim

H-Index: 1

Discovery of a novel potent EGFR inhibitor against EGFR activating mutations and on-target resistance in NSCLC

Clinical Cancer Research

2024/2/8

Ju Young Kim
Ju Young Kim

H-Index: 6

Tae Ho Kim
Tae Ho Kim

H-Index: 20

Min Hee Hong
Min Hee Hong

H-Index: 16

SKYSCRAPER-02: Tiragolumab in Combination With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer

Journal of Clinical Oncology

2024/1/1

Shun Lu
Shun Lu

H-Index: 7

Min Hee Hong
Min Hee Hong

H-Index: 16

Jong-Seok Lee
Jong-Seok Lee

H-Index: 14

Melissa Johnson
Melissa Johnson

H-Index: 3

Meilin Huang
Meilin Huang

H-Index: 4

Aggressive Local Ablative Radiotherapy Mitigates Progression Risk in Oligometastatic Lung Adenocarcinoma

Cancer Research and Treatment: Official Journal of Korean Cancer Association

2024/1

Kyung Hwan Kim
Kyung Hwan Kim

H-Index: 12

Min Hee Hong
Min Hee Hong

H-Index: 16

Hong In Yoon
Hong In Yoon

H-Index: 16

Exploring aryl hydrocarbon receptor expression and distribution in the tumor microenvironment, with a focus on immune cells, in various solid cancer types

Frontiers in Immunology

2024/4/12

So Young Park
So Young Park

H-Index: 6

Youngtaek Kim
Youngtaek Kim

H-Index: 1

Seul Lee
Seul Lee

H-Index: 6

Min Hee Hong
Min Hee Hong

H-Index: 16

Jae Hwan Kim
Jae Hwan Kim

H-Index: 2

A phase II open-label randomized clinical trial of preoperative durvalumab or durvalumab plus tremelimumab in resectable head and neck squamous cell carcinoma

Clinical Cancer Research

2024/4/3

Min Hee Hong
Min Hee Hong

H-Index: 16

Hyunwook Kim
Hyunwook Kim

H-Index: 5

Chan-Young Ock
Chan-Young Ock

H-Index: 20

Jung Eun Lee
Jung Eun Lee

H-Index: 6

Heejung Park
Heejung Park

H-Index: 14

Jin Woo Park
Jin Woo Park

H-Index: 7

Kyung Hwan Kim
Kyung Hwan Kim

H-Index: 12

Inkyung Jung
Inkyung Jung

H-Index: 23

Dawoon Han
Dawoon Han

H-Index: 9

Insuk Lee
Insuk Lee

H-Index: 29

Mingu Kang
Mingu Kang

H-Index: 3

Heon Song
Heon Song

H-Index: 2

Seulki Kim
Seulki Kim

H-Index: 1

Sukjun Kim
Sukjun Kim

H-Index: 3

Miriam Merad
Miriam Merad

H-Index: 86

Enhanced anti-cancer efficacy of the AhR Inhibitor DA-4505 in combination with anti-PD-1 treatment: Attenuation of lung metastasis and elimination of tumor

Cancer Research

2024/3/22

Seul Lee
Seul Lee

H-Index: 6

Jae Hwan Kim
Jae Hwan Kim

H-Index: 2

Min Hee Hong
Min Hee Hong

H-Index: 16

Identification of microbiome and predictive immune biomarkers in patients with advanced non-small lung cancer treated with pembrolizumab with or without chemotherapy

Cancer Research

2024/3/22

Jae Hwan Kim
Jae Hwan Kim

H-Index: 2

Min Hee Hong
Min Hee Hong

H-Index: 16

Patient-derived cells (PDCs) and organoids (PDOs) as critical platforms for developing next therapeutic strategies for NSCLC

Cancer Research

2024/3/22

Sewon Park
Sewon Park

H-Index: 4

Seul Lee
Seul Lee

H-Index: 6

Min Hee Hong
Min Hee Hong

H-Index: 16

Identifying drug tolerant persister to neoadjuvant osimertinib in resectable non-small cell lung cancer harbouring EGFR mutations (NORA) via single-cell RNA sequencing

Cancer Research

2024/3/22

Young Joon Park
Young Joon Park

H-Index: 2

Chang Young Lee
Chang Young Lee

H-Index: 18

Min Hee Hong
Min Hee Hong

H-Index: 16

Clinical utility of a plasma-based comprehensive genomic profiling test in patients with non-small cell lung cancer in Korea

Cancer Treatment and Research Communications

2023/1/1

Seoyoung Lee
Seoyoung Lee

H-Index: 0

Jiyun Lee
Jiyun Lee

H-Index: 17

Min Hee Hong
Min Hee Hong

H-Index: 16

Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer

Nature Cancer

2023/6

Jee Hyun Kim
Jee Hyun Kim

H-Index: 50

Eun Joo Kang
Eun Joo Kang

H-Index: 13

Min Hee Hong
Min Hee Hong

H-Index: 16

Dae Ho Lee
Dae Ho Lee

H-Index: 24

Changhoon Yoo
Changhoon Yoo

H-Index: 23

Jae Ho Jeong
Jae Ho Jeong

H-Index: 8

Sun Young Kim
Sun Young Kim

H-Index: 8

Jung Kyoon Choi
Jung Kyoon Choi

H-Index: 19

See List of Professors in Min Hee Hong University(Yonsei University)